MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$3,810,395
Unit: Dollar
Positive Cash Flow Breakdown
    • Accounts payable and accrued exp...
    • Stock-based compensation expense
    • Provision for credit losses on o...
    • Others
Negative Cash Flow Breakdown
    • Accounts receivable
    • Net (loss) income
    • Deferred tax benefit
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
-
-1,588,281
-302,557
452,176
Net (loss) income
-4,099,467
-
-
-
Bad debt (recovery) expense
-2,954
-
-18,135
-4,089
Amortization expense
320,320
403,467
410,630
217,981
Provision for refund liability
0
108,402
1,522,510
1,413,345
Provision for credit losses on other receivables
739,773
-
377,587
-
Deferred tax benefit
-813,639
-484,472
482,866
12,680
Interest income
15,999
15,999
15,999
16,003
Stock-based compensation expense
959,320
366,562
76,733
292,552
Accounts receivable
4,805,705
2,981,360
-130,475
-416,592
Other receivables
59,704
11,740
-25,705
16,272
Prepaid expenses and other assets
-350,442
-447,597
1,257,519
486,424
Long-term prepaid expenses
-
-
-
-151,000
Operating lease right-of-use assets and liabilities, net
606
605
606
-18
Accounts payable and accrued expenses
2,927,618
1,437,182
312,855
-224,639
Income taxes payable
-
-
0
-34,944
Other current liabilities
0
-1,000,000
-1,500,000
-1,500,000
Net cash (used in) provided by operating activities
-2,912,320
-3,319,247
451,211
673,973
Development of software
596,992
362,131
831,708
744,841
Interest received from loans receivable
-
-
64,000
-
Net cash used in investing activities
-596,992
-362,131
-767,708
-744,841
Proceeds from stock option exercises
-
-
23,430
-
Proceeds from issuance of common stock in connection with private investment in public equity financing, net of placement agent fees and escrow agent fees
0
6,381,000
-
-
Payments of deferred offering costs
199,440
44,168
60,792
43,685
Contributions from noncontrolling interests
71,428
-
-
-
Taxes paid related to net share settlement of equity awards
173,071
-
-
-
Net cash provided by (used in) financing activities
-301,083
6,336,832
-37,362
-43,685
(decrease) increase in cash and cash equivalents
-3,810,395
2,655,454
-353,859
-114,553
Cash and cash equivalents, beginning of period
10,325,208
7,669,754
8,023,613
7,849,248
Cash and cash equivalents, end of period
6,514,813
10,325,208
7,669,754
8,023,613
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

(decrease) increase in cashand cash...-$3,810,395 (-1418.85%↓ Y/Y)Accounts payable andaccrued expenses$2,927,618 (28.98%↑ Y/Y)something is missing$1,588,281 Stock-based compensationexpense$959,320 (-20.13%↓ Y/Y)Provision for creditlosses on other...$739,773 Prepaid expenses andother assets-$350,442 (-271.58%↓ Y/Y)Amortization expense$320,320 (17.78%↑ Y/Y)Contributions fromnoncontrolling interests$71,428 Net cash (used in)provided by operating...-$2,912,320 (-244.99%↓ Y/Y)Net cash used ininvesting activities-$596,992 (63.00%↑ Y/Y)Net cash provided by(used in) financing...-$301,083 (-183.14%↓ Y/Y)Canceled cashflow$6,885,754 Canceled cashflow$71,428 Accounts receivable$4,805,705 (1434.98%↑ Y/Y)Development of software$596,992 (-63.00%↓ Y/Y)Payments of deferredoffering costs$199,440 (87.55%↑ Y/Y)Taxes paid related tonet share...$173,071 Net (loss) income-$4,099,467 Deferred tax benefit-$813,639 (-1122.65%↓ Y/Y)Other receivables$59,704 (-98.22%↓ Y/Y)Interest income$15,999 (-50.00%↓ Y/Y)Bad debt (recovery)expense-$2,954 (-149.32%↓ Y/Y)Operating leaseright-of-use assets and...$606 (1737.84%↑ Y/Y)

Health In Tech, Inc. (HIT)

Health In Tech, Inc. (HIT)